Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Virtual workshop

Daring to be different

If pharma needs to be more rigorous about defining its market insights, recognising opportunities and executing its ‘big idea’, what else gives our best-known consumer brands the leading edge? The...

- PMLiVE

Creating a digital campaign

Are your stakeholders still stuck on rhetoric – playing the waiting game before committing fully to an online presence? Skilfully interacting with a target audience simply means a change of...

- PMLiVE

Digital: tactics first, strategy later?

Pharma's spend on digital continues to grow at 20 per cent per year, according to an annual survey of the digital landscape, yet still only accounts for 7 per cent...

- PMLiVE

Get under their skin

Illuminate the branding process through truly insightful research that provides a deeper understanding of physicians as real people

- PMLiVE

ABPI: UK lags behind Europe for innovation

The UK's NHS lags behind the rest of Europe in terms of access to new treatments said Stephen Whitehead in his first public talk as the organisation's chief executive

Takeda wins UK approval for cancer drug

Takeda's bone cancer treatment Mepact has won the backing of the UK's National Institute for Health and Clinical Excellence

NICE rejects three bowel cancer drugs

The National Institute for Health and Clinical Excellence (NICE) has decided to not recommend three metastatic colorectal cancer drugs as they are not deemed cost effective

- PMLiVE

Interview: Greg Perry, European Generic medicines Association

The director general of the European Generic medicines Association talks to Liz Wells about the challenges facing generic drug manufacturers and discusses how his organisation is working to boost the...

- PMLiVE

Interview: Jorge Gallardo, Almirall

The executive chairman of Spanish pharmaceutical company Almirall explains to PME editor Linda Banks how bold investment in R&D and international expansion are key to the company's growth

New self-care website for NHS

A new self-care website has been launched to provide NHS staff and patient groups with advice, information and practical tools to help encourage people to take care of themselves.

Halaven approved in Japan but not UK

Eisai's breast cancer treatment Halaven has been approved for use in Japan, while England's National Institute for Health and Clinical Excellence has issued draft guidance recommending against use of the...

UK DH commits to value-based pricing

England’s Department of Health has said it will continue to develop a new value-based pricing system for the purchase of drugs to be used in the NHS

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links